Logo image
Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India
Article de revue scientifique   Avec comité de lecture

Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India

C P Thakur, J P Dedet, S Narain et F Pratlong
Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol.95(2), p.187-189
01/03/2001
PMID: 11355558

Résumé

Amphotericin B - therapeutic use Animals Antimony Sodium Gluconate - therapeutic use Antiprotozoal Agents - therapeutic use Drug Resistance Humans India - epidemiology Leishmania donovani - isolation & purification Leishmaniasis, Visceral - drug therapy Leishmaniasis, Visceral - epidemiology Leishmaniasis, Visceral - parasitology Splenic Diseases - drug therapy Splenic Diseases - epidemiology Splenic Diseases - parasitology
Sixteen isolates obtained, in January 1998-December 1999, from splenic aspirates from sodium stibogluconate-resistant cases of visceral leishmaniasis (VL; Indian kala-azar) and drawn from different districts of Bihar (India) were identified as Leishmania donovani. By isoenzyme analysis, all the strains were found identical to the WHO reference strain L. donovani MON-2 and differed from L. tropica MON-5. This study suggested that resistant cases of VL in Bihar were caused by L. donovani and not by L. tropica. No new strain responsible for drug unresponsiveness emerged during this period and other cause or causes of emergence of drug resistance should be sought. All the patients were cured with amphotericin B.

Indicateurs

1 Consultations de la notice

Détails

Logo image